Concepedia

Publication | Open Access

Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma

DOIFull Paper Access

285

Citations

35

References

2020

Year

Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Elizabeth A. Maher, Macarena I. de la Fuente, Matthias Holdhoff, Gregory M. Coté, Howard A. Burris, Filip Jankú, Robert J. Young,
Journal of Clinical Oncology

Abstract

In patients with m<i>IDH1</i> advanced glioma, ivosidenib 500 mg once per day was associated with a favorable safety profile, prolonged disease control, and reduced growth of nonenhancing tumors.

References

YearCitations

Page 1